Compared with Group M0, Proteobacteria showed a trend of decreasing after chemotherapy (M0, 64.50%; M1, 18.77%; M2, 6.41%; M3, 6.43%; M4, 10.97%; M5, 17.76%), while Firmicutes (M0, 31.64%; M1, 64.05%; M2, 78.70%; M3, 74.28%; M4, 74.11%; M5, 75.14%) and Bacteroidetes (M0, 0.99%; M1, 4.72%; M2, 7.32%; M3, 2.52%; M4, 9.69%; M5, 4.44%) were more abundant than before chemotherapy ( Figure 3A ).
← all excerpts
Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy.
1
—
—